Clinical Trials Browser

Phase 2 × INDUSTRY × dapagliflozin × Clear all

NCT04899349 2024-10-09

EPIK-B4

Phase 2 Terminated

2 enrolled 8 charts

Breast Neoplasms, Hyperglycemia, Hereditary Sensory and Autonomic Neuropathies